Pasar al contenido principal

MEDICINA DE PRECISION EN PACIENTES CON APNEA DEL SUEÑO Y SINDROME CORONARIO AGUDO: MODELO PREDICTIVO DE RESPUESTA AL TRATAMIENTO. 

PI18/00449

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (CIBER)
Centro realización HOSPITAL ARNAU DE VILANOVA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea, A post-hoc analysis from the ISAACC study

  • Zapater, Andrea|||0000-0003-0543-2518
  • Gracia-Lavedan, Esther
  • Torres, Gerard|||0000-0002-1417-7320
  • Mínguez, Olga
  • Pascual, Lydia
  • Cortijo, Anunciación
  • Martínez López, Dolores
  • Benitez, Ivan David|||0000-0002-3558-5948
  • De Batlle, Jordi|||0000-0003-3500-6608
  • Henríquez-Beltrán, Mario E.
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Duran-Cantolla, Joaquin|||0000-0001-8172-9415
  • Urrutia Gajate, Amaia|||0000-0002-4088-4088
  • Mediano, Olga|||0000-0001-7824-1523
  • Masdeu, María José|||0000-0003-0437-2074
  • Ordax-Carbajo, Estrella
  • Masa, Juan Fernando
  • De la Peña, Mónica|||0000-0003-3276-776X
  • Mayos, Merce|||0000-0003-3972-3671
  • Coloma Navarro, Ramón|||0000-0002-4280-415X
  • Montserrat, Josep María
  • Chiner, Eusebi|||0000-0003-3374-4623
  • Barbé, Ferran|||0000-0002-2340-8928
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
Obstructive sleep apnea (OSA) is associated with a recurrent cardiovascular event (CVE) risk in patients with a first acute coronary syndrome (ACS). However, the pathological pathways by which OSA promotes this deleterious role are unknown. We aim to explore the proteomic profile associated with OSA that promote the recurrent CVE risk in severe OSA patients with ACS without previous cardiovascular diseases. This post-hoc analysis from the ISAACC study (NCT01335087) included 86 patients admitted for ACS. Patients underwent respiratory polygraphy for the first 24-72 h to OSA diagnosis. We analyzed of 276 cardiovascular and inflammatory related proteins in baseline fasting plasma samples using proximity expression assay technology (Olink®, Sweden). Protein levels were compared between severe OSA patients with/without recurrent CVEs during follow-up. Random forest was conducted to select relevant proteins and generate a predictive model of recurrent CVE. We included 86 patients (median age: 61 years, median BMI: 29.4 kg/m and 86 % males) admitted for ACS with severe OSA (56 without recurrent CVE/30 with recurrent CVE). The plasma levels of 38 proteins were differentially expressed between groups. Additionally, 12 proteins had a significant association with respiratory polygraphy parameters. Three proteins discriminate with an AUC of 0.81 (95 % CI of 0.71-0.9) between severe OSA patients with and without recurrent CVE. These proteins were implicated in cell proliferation, communication and apoptosis, and regulation/response to the inflammatory and immune systems. In ACS patients with severe OSA, a proteomic profile was associated with recurrent CVEs. This proteomic profile was correlated with specific OSA parameters from respiratory polygraphy. Proteomic profiling may provide an new direction for patient risk stratification and clinical management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Pulse Wave Amplitude Drops Index, A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea

  • Solelhac, Geoffroy|||0000-0002-7135-133X
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
  • Blanchard, Margaux|||0000-0001-8382-4037
  • Berger, Mathieu
  • Hirotsu, Camila
  • Imler, Théo
  • Sánchez de la Torre, Alicia|||0000-0003-3446-1481
  • Haba-Rubio, José
  • Marchi, Nicola Andrea|||0000-0002-7809-4399
  • Bayon, Virginie
  • Bailly, Sébastien|||0000-0002-2179-4650
  • Goupil, François
  • Waeber, Adrien
  • Heiniger, Grégory
  • Pigeanne, Thierry
  • Gracia-Lavedan, Esther
  • Zapater, Andrea|||0000-0003-0543-2518
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Ordax, Estrella
  • Masdeu, María José|||0000-0003-0437-2074
  • Cabriada-Nuño, Valentín|||0000-0003-1124-7108
  • Egea, Carlos J.
  • Van Den Broecke, Sandra
  • Vollenweider, Peter|||0000-0002-0765-896X
  • Marques-Vidal, Pedro|||0000-0002-4548-8500
  • Vaucher, Julien
  • Bernardi, Giulio
  • Betta, Monica
  • Siclari, Francesca
  • Barbé, Ferran|||0000-0002-2340-8928
  • Gagnadoux, Frédéric|||0000-0002-4231-5102
  • Heinzer, Raphael|||0000-0002-3215-7788
It is currently unclear which patients with obstructive sleep apnea (OSA) are at increased cardiovascular risk. To investigate the value of pulse wave amplitude drops (PWADs), reflecting sympathetic activations and vasoreactivity, as a biomarker of cardiovascular risk in OSA. PWADs were derived from pulse oximetry-based photoplethysmography signals in three prospective cohorts: HypnoLaus (N = 1,941), the Pays-de-la-Loire Sleep Cohort (PLSC; N = 6,367), and "Impact of Sleep Apnea syndrome in the evolution of Acute Coronary syndrome. Effect of intervention with CPAP" (ISAACC) (N = 692). The PWAD index was the number of PWADs (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Respiratory Polygraphy Patterns and Risk of Recurrent Cardiovascular Events in Patients With Acute Coronary Syndrome

  • Zapater, Andrea|||0000-0003-0543-2518
  • Solelhac, Geoffroy|||0000-0002-7135-133X
  • Sánchez de la Torre, Alicia|||0000-0003-3446-1481
  • Gracia-Lavedan, Esther
  • Benitez, Ivan David|||0000-0002-3558-5948
  • Torres, Gerard|||0000-0002-1417-7320
  • De Batlle, Jordi|||0000-0003-3500-6608
  • Haba-Rubio, José
  • Berger, Mathieu
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Duran-Cantolla, Joaquin|||0000-0001-8172-9415
  • Urrutia Gajate, Amaia|||0000-0002-4088-4088
  • Mediano, Olga|||0000-0001-7824-1523
  • Masdeu, María José|||0000-0003-0437-2074
  • Ordax-Carbajo, Estrella
  • Masa, Juan Fernando
  • De la Peña, Mónica|||0000-0003-3276-776X
  • Mayos, Merce|||0000-0003-3972-3671
  • Coloma, Ramon
  • Montserrat, Josep María
  • Chiner, Eusebi|||0000-0003-3374-4623
  • Mínguez, Olga
  • Pascual, Lydia
  • Cortijo, Anunciación
  • Martínez López, Dolores
  • Dalmases, Mireia
  • Lee, Chi-Hang
  • McEvoy, R. Doug
  • Barbé, Ferran|||0000-0002-2340-8928
  • Heinzer, Raphael|||0000-0002-3215-7788
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
Obstructive sleep apnea (OSA) severity is based on the apnea-hypopnea index (AHI). The AHI is a simplistic measure that is inadequate for capturing disease severity and its consequences in cardiovascular diseases (CVDs). Deleterious effects of OSA have been suggested to influence the prognosis of specific endotypes of patients with acute coronary syndrome (ACS). We aim to identify respiratory polygraphy (RP) patterns that contribute to identifying the risk of recurrent cardiovascular events in patients with ACS. Post hoc analysis of the ISAACC study, including 723 patients admitted for a first ACS (NCT01335087) in which RP was performed. To identify specific RP patterns, a principal component analysis (PCA) was performed using six RP parameters: AHI, oxygen desaturation index, mean and minimum oxygen saturation (SaO), average duration of events and percentage of time with SaO < 90%. An independent HypnoLaus population-based cohort was used to validate the RP components. From the ISAACC study, PCA showed that two RP components accounted for 70% of the variance in the RP data. These components were validated in the HypnoLaus cohort, with two similar RP components that explained 71.3% of the variance in the RP data. The first component (component 1) was mainly characterized by low mean SaO and obstructive respiratory events with severe desaturation, and the second component (component 2) was characterized by high mean SaO and long-duration obstructive respiratory events without severe desaturation. In the ISAACC cohort, component 2 was associated with an increased risk of recurrent cardiovascular events in the third tertile with an adjusted hazard ratio (95% CI) of 2.44 (1.07 to 5.56; p -value = 0.03) compared to first tertile. For component 1, no significant association was found for the risk of recurrent cardiovascular events. A RP component, mainly characterized by intermittent hypoxemia, is associated with a high risk of recurrent cardiovascular events in patients without previous CVD who have suffered a first ACS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea, a post hoc study of the ISAACC trial

  • Pinilla, Lucía|||0000-0003-2825-4056
  • Esmaeili, Neda
  • Labarca, Gonzalo|||0000-0002-0069-3420
  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Torres, Gerard|||0000-0002-1417-7320
  • Gracia-Lavedan, Esther
  • Mínguez, Olga
  • Martínez López, Dolores
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Masdeu, Maria José
  • Mediano, Olga|||0000-0001-7824-1523
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Cabriada-Nuño, Valentín|||0000-0003-1124-7108
  • Duran-Cantolla, Joaquin|||0000-0001-8172-9415
  • Mayos, Merce|||0000-0003-3972-3671
  • Coloma Navarro, Ramón|||0000-0002-4280-415X
  • Montserrat, Josep María
  • De la Peña, Mónica|||0000-0003-3276-776X
  • Hu, Wen-Hsin
  • Messineo, Ludovico
  • Sehhati, Mohammadreza
  • Wellman, Andrew
  • Redline, Susan
  • Sands, Scott
  • Barbé, Ferran|||0000-0002-2340-8928
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
  • Azarbarzin, Ali|||0000-0002-4986-4753
Hypoxic burden (HB) has emerged as a strong predictor of cardiovascular risk in obstructive sleep apnoea (OSA). We aimed to assess the potential of HB to predict the cardiovascular benefit of treating OSA with continuous positive airway pressure (CPAP). This was a post hoc analysis of the ISAACC trial (: NCT01335087) including non-sleepy patients with acute coronary syndrome (ACS) diagnosed with OSA (apnoea-hypopnoea index ≥15 events·h -1) by respiratory polygraphy. Patients were randomised to CPAP or usual care and followed for a minimum of 1 year. HB was calculated as the total area under all automatically identified desaturations divided by total sleep time. Patients were categorised as having high or low baseline HB according to the median value (73.1%min·h -1). Multivariable Cox regression models were used to assess whether the effect of CPAP on the incidence of cardiovascular outcomes was dependent on the baseline HB level. The population (362 patients assigned to CPAP and 365 patients assigned to usual care) was middle-aged (mean age 59.7 years), overweight/obese and mostly male (84.5%). A significant interaction was found between the treatment arm and the HB categories. In the high HB group, CPAP treatment was associated with a significant reduction in the incidence of cardiovascular events (HR 0.57, 95% CI 0.34-0.96). In the low HB group, CPAP-treated patients exhibited a trend toward a higher risk of cardiovascular outcomes than those receiving usual care (HR 1.33, 95% CI 0.79-2.25). The differential effect of the treatment depending on the baseline HB level followed a dose-response relationship. In non-sleepy ACS patients with OSA, high HB levels were associated with a long-term protective effect of CPAP on cardiovascular prognosis.